Our Take
Public quantum enthusiasm masks a private funding retreat: startups are seeing fewer dollars despite bigger individual rounds, while the field waits for Quantinuum's IPO pricing to reset expectations.
Why it matters
Quantum computing investors are now split between betting on proven public players and backing private startups at inflated valuations. If Quantinuum prices below its $10B private round, it signals the market is recalibrating what the technology is actually worth.
Do this week
Investors: map your quantum portfolio against the four public pure-plays (D-Wave, IonQ, Quantum Computing, Rigetti) before Quantinuum's IPO pricing, so you can benchmark private round valuations against public-market expectations.
Private funding trails last year despite larger rounds
Quantum computing startups raised $1.2 billion in seed-through-growth-stage funding through mid-2026, putting the year on track to fall below 2025's record $4.1 billion haul (per Crunchbase data). Deal count remains healthy, and three consecutive months of large closings have punctuated the slowdown.
The biggest 2026 round came last week: Photonic, a Vancouver-based quantum computing and quantum network platform, closed a $200 million Series round at a $2 billion valuation (company-reported). The same month saw QuantWare, a Dutch fab-focused startup, secure $178 million in Series B, and Quantum Motion, a London-based silicon-based quantum player, announce $160 million in Series C led by DCVC and Kembara.
These standouts mask the broader contraction. Startups are pulling in materially fewer total dollars than 2025, even as individual rounds grow larger. That pattern suggests capital is concentrating on fewer, later-stage bets.
Public quantum is where investor conviction lives
The four largest pure-play public quantum companies—D-Wave Quantum, IonQ, Quantum Computing, and Rigetti Computing—carry a combined market cap of roughly $36 billion (company-reported). Xanadu, a Canadian photonic platform, added another $5 billion in market cap after going public via SPAC merger this spring on Nasdaq and the Toronto Stock Exchange.
These public names are actively acquiring private startups at steep prices. IonQ paid $1.08 billion for Oxford Ionics last year; D-Wave bought Quantum Circuits for $550 million in stock and cash earlier this year. Both moves signal that public quantum companies see acquisition as faster than organic capability building.
The real test comes in the coming weeks. Quantinuum, majority-owned by Honeywell and valued at $10 billion in its last private round (September 2025), has filed to go public on Nasdaq. Its IPO pricing will reset the market's belief about quantum valuations. If it prices below $10 billion, expect private funding rounds to face downward pressure. If it prices well above, expect more SPAC and traditional IPO candidates to file.
Watch Quantinuum's IPO and the deal value cascade
Quantinuum's public debut is the first real market validation of full-stack quantum platform economics. Its pre-money valuation was $10 billion; the market will price it based on revenue, R&D spend, customer commitments, and path to profitability (none of which have been disclosed publicly). That gap between private and public price will ripple through every follow-on quantum funding round.
Private quantum startups funded in late 2025 and early 2026 may face repricing pressure if the IPO signals lower enterprise value. Conversely, a strong IPO could unlock a new wave of SPACs and direct listings. Either way, the next six weeks compress what would normally take a year: the field moves from optimism toward a measurable price signal.